​The midseason moment has arrived to take a clear-eyed look at the fantasy baseball landscape. Which players are outperforming expectations and ripe for a sell-high move? Who is underperforming and could be bought low? There are plenty of promising targets to consider. The analysis below makes a strong case for the players highlighted.
The Phillies’ All-Star is a prime candidate to sell, given his current over-performance. Marsh has never posted a batting average higher than .280 across his five prior MLB seasons, and he has never exceeded 60 RBIs in a single year or reached 16 home runs. Yet this season he is hitting .305 with 46 RBIs and 15 homers, a pace well above his historical benchmarks. There has already been a hint of regression in early July, with his average dropping to .143 for the month so far. When Marsh was drafted, he was taken as the OF108 in fantasy leagues, and the arithmetic of the season suggests a continued drift toward a more normal, lower production level.
The Diamondbacks’ ace is delivering unsustainable production. Following a World Baseball Classic victory, he has posted a sparkling 2.25 ERA, but his strikeout rate stands at just 6.19 K/9. Across his 11-season career, he has four sub-3.50 ERAs and only four sub-4.00 ERAs, underscoring that a lot of his current numbers are not built on a durable foundation. May was his strongest month, with a 1.60 ERA, and June remained strong at a 2.02 ERA. In his lone July start so far, he allowed two runs across six innings. This looks like a setup for regression back toward a 3.00 ERA or higher rather than a collapse to below 2.00.
The Dodgers’ catcher is nearing a return, making him a risky hold and a potentially strong buy when healthy. Leaving him on the bench or passing on a Dodgers starter would be unwise. He posted .270 across March and April and .239 in May, with only a June slump before his injury, during which he hit .154. The 2025 season stands as his best to date, featuring a +24.3 offensive rating, and he has never posted a below-average offensive rating in his eight-year MLB career. Acquiring him now before his return could yield substantial gains as he resumes his usual contributing pace.
Luzardo entered the season as a legitimate longshot for Cy Young consideration, but a rough start cooled those expectations. He posted a 5.50 ERA in March and April, yet has since trimmed that figure with a 3.03 ERA in May, 2.97 in June, and a 1.50 ERA in July thus far. A second-half surge appears increasingly likely, making him a compelling buy-low target for the stretch run.
This midseason window is also a reminder that injuries and health can dramatically swing value, especially with players like Byron Buxton, whose status as an All-Star could eventually translate into a return to full health and productivity for fantasy rosters. Similarly, familiar names like Robbie Ray continue to surface as attractive landing spots in optimistic projections, along with frequent discussions about Michael Wacha’s best-fit destinations and how those scenarios could maximize fantasy output.
In summary, the current landscape presents several buy-low and sell-high opportunities as we approach the second half of the season. The players highlighted here exhibit clear reasons to consider capitalizing on their recent trendlines, either by selling high while the moment remains favorable or by buying low before a notable price increase or return to form. This snapshot, originally appearing on SI’s fantasy coverage, consolidates the most actionable midseason intel for fantasy baseball managers seeking to refine their rosters.